A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

Disruption of the methionine cycle in tumor-initiating cells disarms their tumorigenic capabilities, researchers say.

A*STAR researchers have devised a method that can detect and distinguish closely related flaviviruses with 100 percent accuracy.

Proteomics expert Ruedi Aebersold discusses the use of multiplex targeted mass spectrometry for one-shot flavivirus diagnosis.

Researchers have obtained a high-resolution structure of the RIP2 protein complex and detailed its interactions with other immune proteins.

A*STAR researchers have uncovered the sequence of genetic events behind the development of motile cilia in airways.

Cancer cells evade Taxol-induced cell death by downregulating the expression of a protein known as BimEL.

By triggering the Wnt signaling pathway, A*STAR scientists were able to reactivate proliferation in mature human heart muscle cells.

When parts of a bacteria’s cell wall enter into circulation, its host experiences more severe autoimmune reactions.

Microfluidic device allows for precise control of growth factor gradients, mimicking natural spinal cord development in vitro.

Injecting flies with snail venom could help us discover molecules for developing new drugs

Drug screen reveals safe, potent, broad-spectrum anticancer compound

New spinal-cord-like cell clusters could be used to study and find treatments for nerve cell degeneration